PMC 3735344
Non-alcoholic fatty liver disease is a progressive disease, without effective intervention, can gradually deteriorate into non-alcoholic steatohepatitis, fatty liver fibrosis, liver cirrhosis and even liver cancer, and may become the main cause of end-stage liver disease in the future [11]
A foundational 1999 study showed that topical or systemic thymosin 4 accelerated dermal wound re-epithelialization by roughly 4060% in rodent models, with increased collagen deposition and angiogenesis
How do I minimize discomfort during injections
References: Baar MP, Brandt RMC, Putavet DA, Klein JDD, Derks KWJ, Bourgeois BRM, Stryeck S, Rijksen Y, van Willigenburg H, Feijtel DA, van der Pluijm I, Essers J, van Cappellen WA, van IJcken WF, Houtsmuller AB, Pothof J, de Bruin RWF, Madl T, Hoeijmakers JHJ, Campisi J, de Keizer PLJ